Procter & Gamble
PG
$146.13
+0.59%
Procter & Gamble is a global consumer staples manufacturer founded in 1837, operating a portfolio of more than 20 billion-dollar brands — including Tide, Charmin, Pampers, and Pantene — across five reporting segments: Fabric Care & Home Care, Baby/Feminine/Family Care, Beauty, Health Care, and Grooming, with roughly half of consolidated sales generated outside the United States. As one of the world's largest and most durable consumer product franchises, P&G is a classic defensive compounder prized for brand equity, pricing power, and an unbroken dividend record that has earned it Dividend King status. The current investor debate centers on whether P&G's volume growth can reaccelerate after management issued fiscal 2027 guidance below consensus, citing approximately $1.36 billion in cost headwinds, even as the company continues to post mid-single-digit revenue growth and expanding margins. With the stock trading near the lower end of its 52-week range while the broader market has rallied, the narrative has shifted from 'safe-haven compounder' to 'show-me story' — investors are weighing the durability of P&G's pricing-led growth against a consumer staples sector facing tariff pressure, European energy cost inflation, and intensifying competition from private label.…
PG
Procter & Gamble
$146.13
Related headlines
Investment Opinion: Should I buy PG Today?
Rating: Hold. PG is a high-quality defensive compounder with a safe 2.88% dividend yield and a strong balance sheet, but near-term headwinds and sluggish volume growth limit upside. The analyst consensus rating is Buy with an average target of $160.61, implying 10.6% upside, but we believe the risk/reward is balanced until volume trends improve. The stock is fairly valued at 19.6x forward earnings, and we recommend holding for income and stability rather than aggressive growth.
Supporting Evidence: PG trades at a forward PE of 19.6x and a trailing PE of 21.7x, below its historical average of ~24x. Revenue grew 7.4% YoY in Q3 2026, but this was entirely price-driven. Gross margin is 50.2%, operating margin 22.7%, and net margin 18.4%, all healthy but showing signs of pressure. Free cash flow TTM is $15.0B, comfortably covering the $9.6B annual dividend (payout ratio 63.8%). The dividend yield of 2.88% is attractive relative to the 10-year Treasury yield of ~4.2%, but the stock's 8.4% YoY decline reflects growth concerns.
Risks & Conditions: The biggest risks are a continued decline in volume growth, margin erosion from cost inflation, and a further rotation out of consumer staples. This Hold would upgrade to Buy if volume growth turns positive and the stock pulls back to $135-$140 (yielding ~3.1%), or if cost headwinds prove transitory and margins stabilize. It would downgrade to Sell if organic volume declines accelerate, gross margin falls below 48%, or the dividend payout ratio exceeds 70%. Relative to its history and peers, PG is fairly valued to slightly undervalued, but lacks a near-term catalyst.
Sign up to view all
PG 12-Month Price Forecast
P&G is a high-quality defensive stock trading at a reasonable valuation, but near-term headwinds and weak volume growth limit upside. The analyst consensus target of $160.61 implies 10.6% upside, but we believe the stock will likely trade in a range of $150-$165 over the next 12 months. The key catalyst is volume growth; without it, the stock may continue to lag the market. We would upgrade to bullish if volume growth turns positive and margins stabilize, and downgrade to bearish if volume declines accelerate or cost headwinds intensify.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Procter & Gamble's 12-month outlook, with a consensus price target around $160.61 and implied upside of +9.9% versus the current price.
Average Target
$160.61
0 analysts
Implied Upside
+9.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$143 - $186
Analyst target range
Drowning in data?
Find the real signal!
Bulls vs Bears: PG Investment Factors
The bear case currently has stronger evidence due to the recent guidance cut, volume stagnation, and significant relative underperformance. The bull case rests on valuation support, dividend safety, and potential mean reversion. The single most important tension is whether P&G can return to positive volume growth; if it does, the stock could re-rate toward the analyst average target of $160.61, but if volumes remain weak, the stock could test the 52-week low of $137.62.
Bullish
- Attractive Valuation vs. History: PG trades at a trailing PE of 21.7x and a forward PE of 19.6x, below its five-year average of ~24x. The PEG ratio of 18.1 appears elevated, but that reflects a low near-term growth rate; on a normalized basis, the stock is inexpensive for a Dividend King with a 2.88% yield.
- Consistent Dividend Growth: PG has paid dividends for over 130 years and has raised them for 68 consecutive years. The current yield of 2.88% is well-supported by a payout ratio of 63.8% and free cash flow of $15.0B, ensuring continued dividend growth.
- Strong Profitability and Cash Flow: Gross margin stands at 50.2%, operating margin at 22.7%, and net margin at 18.4%. ROE is an impressive 29.5%, and free cash flow TTM is $15.0B, providing ample resources for dividends, buybacks, and debt reduction.
- Analyst Consensus Upside: 23 analysts rate PG a Buy with an average target of $160.61, implying 10.6% upside from the current price of $145.27. The high target of $186 suggests 28% upside if volume growth reaccelerates.
Bearish
- Guidance Disappointment: Management issued fiscal 2027 guidance below consensus, citing $1.36B in cost headwinds. This has shifted the narrative from 'safe-haven compounder' to 'show-me story,' pressuring the stock.
- Volume Growth Stagnation: Revenue growth of 7.4% YoY in Q3 2026 was driven by pricing, not volume. Organic volume growth has been flat to negative in key segments, raising concerns about the sustainability of growth.
- Relative Underperformance: PG has underperformed the S&P 500 by 24.6% over the past year and 19.0% over six months. The stock is down 8.4% YoY while the market has rallied, indicating waning investor confidence.
- Margin Pressure from Costs: Gross margin declined from 51.2% in Q2 2026 to 49.5% in Q3 2026. European energy cost inflation and tariff pressures are expected to keep margins under pressure in the near term.
PG Technical Analysis
Beta
0.38
0.38x market volatility
Max Drawdown
-16.1%
Largest decline past year
52-Week Range
$138-$167
Price range past year
Annual Return
-7.5%
Cumulative gain past year
| Period | PG Return | S&P 500 |
|---|---|---|
| 1m | +1.1% | -2.0% |
| 3m | -4.2% | +1.4% |
| 6m | -0.4% | +15.0% |
| 1y | -7.5% | +15.7% |
| ytd | +3.1% | +11.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PG Fundamental Analysis
Quarterly Revenue
$21.2B
2026-03
Revenue YoY Growth
+7.4%
YoY Comparison
Gross Margin
49.5%
Latest Quarter
Free Cash Flow
$15.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PG Overvalued?
PE
21.7x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 19x~31x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: P&G carries a debt-to-equity ratio of 0.64, which is manageable but not insignificant. The current ratio of 0.68 indicates potential liquidity tightness, though this is typical for a company with strong cash flow. The $1.36B cost headwind for fiscal 2027 poses a direct threat to margins, which have already shown volatility, with gross margin falling from 51.2% in Q2 2026 to 49.5% in Q3 2026. Additionally, the company's revenue is heavily reliant on pricing, as volume growth has been stagnant, making it vulnerable to consumer downtrading and private-label competition.
Market & Competitive Risks: PG's beta of 0.38 suggests low correlation with the market, but the stock has underperformed the S&P 500 by 24.6% over the past year, indicating sector rotation away from consumer staples. The stock trades at a forward PE of 19.6x, which is a premium to the broader market's forward PE of ~18x, despite lower growth prospects. Competitive pressures from private label and smaller brands are intensifying, particularly in the U.S. and Europe. Recent news highlights European energy cost inflation and tariff pressures, which could further erode margins and market share.
Worst-Case Scenario: A worst-case scenario would involve a continued decline in volume growth, margin compression from cost headwinds, and a broader market rotation out of defensive stocks. If PG fails to deliver on its fiscal 2027 guidance and volumes remain negative, the stock could test its 52-week low of $137.62, representing a 5.3% decline from the current price of $145.27. In a more severe scenario, if the market re-rates the stock to a PE of 18x on forward EPS of $7.37, the price could fall to $132.66, a 8.7% drop. The maximum drawdown over the past year was -16.15%, indicating that a decline to the low $120s is possible in a prolonged bear market.
FAQ
The key risks include: 1) Financial risk: $1.36B in cost headwinds could compress margins further, with gross margin already falling to 49.5% in Q3 2026. 2) Competitive risk: private-label competition and consumer downtrading could lead to volume declines, as seen in recent quarters. 3) Macro risk: European energy cost inflation and tariff pressures could increase operating costs, while a strong dollar could hurt international sales (over 50% of revenue). 4) Company-specific risk: failure to innovate or adapt to changing consumer preferences could erode market share. The most severe risk is a sustained volume decline, which could trigger a dividend cut or a significant stock price decline.
Our 12-month forecast for PG includes three scenarios: Bull case (25% probability) with a target range of $170-$186, driven by positive volume growth and margin expansion. Base case (55% probability) with a target range of $150-$165, assuming modest revenue growth and stable margins. Bear case (20% probability) with a target range of $130-$143, if volume declines accelerate and cost headwinds intensify. The base case is most likely, with a target of $160, implying 10% upside. The key assumption is that P&G can offset cost headwinds with productivity savings and maintain its dividend.
PG appears fairly valued to slightly undervalued relative to its history. The forward PE of 19.6x is below its five-year average of ~24x, and the dividend yield of 2.88% is above its historical average of ~2.5%. However, the PEG ratio of 18.1 is elevated, reflecting low growth expectations. Compared to peers like Kimberly-Clark (forward PE ~18x) and Colgate-Palmolive (forward PE ~22x), PG trades in line. The market is pricing in modest growth and margin pressure, but not a severe downturn. If volume growth returns, the stock could re-rate toward 22x forward earnings, implying a price of ~$162.
PG is a good buy for income-focused investors seeking a safe dividend and low volatility, but it may not be ideal for those seeking high growth. The stock offers a 2.88% dividend yield, a forward PE of 19.6x, and a 10.6% upside to the analyst average target of $160.61. However, the company faces near-term headwinds, including $1.36B in cost pressures and stagnant volume growth. The biggest downside risk is a test of the 52-week low at $137.62, representing a 5.3% decline. For long-term investors, PG is a solid core holding, but waiting for a pullback to $135-$140 would provide a better entry point.
PG is best suited for long-term investment, ideally with a holding period of at least 3-5 years. Its low beta of 0.38 and reliable dividend make it a low-volatility compounder, but near-term headwinds could keep the stock range-bound. Short-term trading is not recommended due to limited catalysts and low volatility. For income investors, the 2.88% yield and 68-year dividend growth streak provide a safe stream of income. A minimum holding period of 3 years is suggested to ride out cyclical pressures and benefit from potential multiple expansion.
